| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $69.6M | -66.9% |
| Cost of Revenue | $2.5M | -23.4% |
| R&D Expense | $127.1M | -31.8% |
| SG&A Expense | $48.4M | -35.0% |
| Operating Income | -$166.0M | -34.6% |
| Interest Expense | $46.3M | +26.1% |
| Pre-tax Income | -$195.4M | -33.1% |
| Income Tax | $39.1M | — |
| Net Income | -$240.1M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $278.6M | -14.7% |
| Accounts Receivable | $25.2M | -65.5% |
| Inventory | $16.2M | +34.0% |
| Current Assets | $336.3M | -22.7% |
| Total Assets | $354.8M | -27.7% |
| Current Liabilities | $67.7M | -17.4% |
| Total Liabilities | $503.0M | +22.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$118.7M | +14.2% |
| Capital Expenditures | $3.2M | +368.1% |
| Investing Cash Flow | -$3.2M | -368.1% |
| Financing Cash Flow | $73.9M | +8335.8% |
| Free Cash Flow | -$121.9M | +12.3% |
| -52.8% |
| EPS (Basic) | -$2.94 | -46.3% |
| EPS (Diluted) | -$2.94 | -46.3% |
| Stockholders' Equity |
| -$148.2M |
| -286.6% |